The Recall Desk

Manufacturer

Macleods Pharmaceuticals Ltd

3 recalls in our database name Macleods Pharmaceuticals Ltd as the manufacturing or recalling firm.

What the numbers show

Total
3
Critical
0
Severe
0
Most recent
2025-07-16

Of the 3 recalls from Macleods Pharmaceuticals Ltd we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–3 of 3

  • ModerateFDA (Drugs)·D-0509-2025·2025-07-16

    Famciclovir tablets recalled after a hair was found on a tablet

    Famciclovir Tablets USP 500 mg from Macleods Pharma are being recalled because a black hair strand was found attached to a tablet in a sealed bottle. 9,888 bottles are affected.

    Product
    FAMCICLOVIR — FAMCICLOVIR (FAMCICLOVIR)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0470-2025·2025-06-18

    Levothyroxine Sodium tablets recalled for foreign substance contamination

    Macleods Pharmaceuticals is recalling Levothyroxine Sodium 112 mcg tablets (Lot #MLF2401A, expiration 01/31/2026) distributed nationwide due to black hair found embedded in tablets.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0154-2025·2024-12-25

    Olanzapine 2.5 mg Tablets Recalled for Failed Impurity Specifications

    Macleods Pharmaceuticals is recalling Olanzapine 2.5 mg tablets nationwide due to failed impurities and degradation specifications. The recall affects one production lot distributed across the United States.

    Product
    OLANZAPINE — OLANZAPINE (OLANZAPINE)
    Category
    Drug
    Distribution
    Distributed nationwide